Search for: "GlaxoSmithKline LLC" Results 1 - 20 of 124
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2014, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit issued an opinion on Monday in GlaxoSmithKline LLC v. [read post]
25 Jun 2017, 9:25 pm by Patent Docs
District Court Overrules Defendants' Objections to Magistrate's Report on Lost Profits By Donald Zuhn -- Earlier this month, in GlaxoSmithKline LLC v. [read post]
17 Apr 2013, 9:59 pm by Patent Docs
GlaxoSmithKline LLC, the Federal Circuit affirmed the determination by the District Court for the Southern District of California that the claim term "anti-CD20 antibody" as used in U.S. [read post]
27 Jul 2014, 9:38 pm by Patent Docs
GlaxoSmithKline LLC et al. v. [read post]
2 Jul 2012, 9:42 pm by A. Brian Albritton
Department of Justice announced today that "global health care giant" GlaxoSmithKline LLC ("GSK") agreed to plead guilty and to pay $3 billion to resolve "its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices." [read post]
16 Jan 2011, 9:17 pm by Patent Docs
GlaxoSmithKline LLC v. [read post]
17 Jul 2015, 12:50 pm by Tom Lamb
From their legal document "BRIEF IN SUPPORT OF DEFENDANT GLAXOSMITHKLINE LLC’S MOTION FOR TRANSFER OF ACTIONS PURSUANT TO 28 U.S.C. [read post]
28 Mar 2010, 8:33 pm by Patent Docs
Glaxosmithkline LLC et al. 3:10-cv-00608; filed March 24, 2010 in the Southern District of California • Plaintiffs: Biogen Idec, Inc.; Genentech, Inc. • Defendants: Glaxosmithkline LLC; Glaxo Group Ltd. [read post]
8 Mar 2016, 11:22 am by Broussard & David
Lafleur, a minor, filed suit against GlaxoSmithKline LLC on February 23 in the U.S. [read post]
25 Nov 2020, 9:45 am by Steve Brachmann
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]
25 Nov 2014, 9:55 pm by Patent Docs
• Defendants: Glaxosmithkline LLC; Aptalis Pharma US, Inc.; Aptalis Pharmatech, Inc.; Aptalis Pharma Canada Inc. [read post]
25 Nov 2020, 9:45 am by Steve Brachmann
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]